Journal of Acupuncture Research

  • 제32권4호
  • /
  • Pages.133-145
  • /
  • 2015
  • /
  • 2586-288X(pISSN)
  • /
  • 2586-2898(eISSN)
대한침구의학회 (Korean Acupuncture & Moxibustion Medicine Society)
권호 표지
DOI QR코드

DOI QR Code

근위축성 측삭경화증의 한방치료에 관한 문헌적 고찰연구

A Literature Review of Korean Medical Studies of Amyotrophic Lateral Sclerosis (ALS)

  • 김경민 (대전대학교 한의과대학 침구의학교실) ;
  • 김정호 (대전대학교 한의과대학 침구의학교실) ;
  • 김영일 (대전대학교 한의과대학 침구의학교실) ;
  • 전주현 (대전대학교 한의과대학 침구의학교실)
  • Kim, Kyung Min (Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Daejeon University) ;
  • Kim, Jung Ho (Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Daejeon University) ;
  • Kim, Young Il (Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Daejeon University) ;
  • Jeon, Ju Hyun (Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Daejeon University)
  • 투고 : 2015.11.11
  • 심사 : 2015.11.27
  • 발행 : 2015.12.18
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives : There have been many reports that show that Korean Medical Treatment of ALS patients can maintain or improve their major and minor symptoms, but this has not been reviewed in literature. The aim of this study is to review studies of ALS patients treated with Korean Medicine. Methods : A search was completed of studies containing word ALS in English and in Korean from KIOM OASIS. Results : There were no cases of ALS patients that were fully cured. However with Korean Medical treatment, there were articles that reported improvement or maintenance of major symptoms, recovery of minor symptoms like pain, chest discomfort, insomnia, cough, sputum, etc, and success in the long term care of ALS patients. Conclusions : Although the current study has limitations, our findings support the potential use and effectiveness of Korean Medical Treatment for ALS patients.

키워드

참고문헌

  1. PN Gordon. Amyotrophic lateral sclerosis: an updatefor2013clinical features.pathophysiology management and therapeutic trials. Aging Dis. 2013 ; 4(5) : 295-310. https://doi.org/10.14336/AD.2013.0400295
  2. Caroscio JT, Mulvihill MN, Sterling R, Abrams B. Amyotrophic lateral sclerosis, its natural history. Neurol Clin. 1987 ; 5(1) : 1-8. https://doi.org/10.1016/S0733-8619(18)30931-9
  3. Mulder DW. Motor neuron disease. In: Dyck PJ, Thomas PK, Lambert EH et el. Peripheral neuropathy. 2nd ed. Vol. 2. Philadelphia, PA : WB Saunders. 1984 : 1525-36.
  4. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain. 1995 ; 118(3) : 707-19. https://doi.org/10.1093/brain/118.3.707
  5. Bellingham MC. A review of theneural mechanisms of action and clinical efficiency of Riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade? CNS Neurosci Ther. 2011 ; 17(1) : 4-31. https://doi.org/10.1111/j.1755-5949.2009.00116.x
  6. Kim SH. Diagnosis and Therapeutic Strategies of Amyotrophic Lateral Sclerosis. Hanyang Med Rev. 2006 ; 26(1) : 44-51.
  7. Adams Principles of Neurology compilation committee. Adams Principles of Neurology. Seoul : Jeongdam. 1998 : 1003-9.
  8. Korean Neurosurgical Society. Neurosurgery. Seoul : Joongangmunhwasa. 1998 : 48-9.
  9. Shin JY, Lee KW. Diagnosis and management of amyotrophic lateral sclerosis. J Korean Med Assoc. 2015 ; 58(2) : 131-8. https://doi.org/10.5124/jkma.2015.58.2.131
  10. Siklos L, Engelhardt HI, Reaume AG et al. Alteredcalcium homeostasis in spinal motoneurons but notin oculomotor neurons of SOD-1 knockout mice. Acta Neuropathol.2000 ; 99(5) : 517-24. https://doi.org/10.1007/s004010051154
  11. Logroscino G, Traynor BJ, Hardiman O et el. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010 ; 81(4) : 385-90. https://doi.org/10.1136/jnnp.2009.183525
  12. Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study. Neurology. 2009 ; 72(19) : 1640-5. https://doi.org/10.1212/WNL.0b013e3181a55f7b
  13. Gordon PH, Salachas F, Lacomblez L et el. Predicting survival of patients with amyotrophic lateral sclerosis at presentation: a 15-year experience. Neurodegener Dis. 2013 ; 12(2) : 81-90. https://doi.org/10.1159/000341316
  14. Baek WK, Park AR, Kim HY, Kin SH. Amyotrophic Lateral Sclerosis in Korea: Clinical Characteristics and Prognostic Factors. J Korean Neurol Assoc. 2011 ; 29(1) : 16-24.
  15. John R. Patrick L, Brad S. Amyotrophic Lateral Sclerosis Micronomics. Phys Med Rehabil Clin N Am. 2005 ; 16(4) : 909. https://doi.org/10.1016/j.pmr.2005.08.007
  16. Wang H, O'Reilly EJ, Weisskopf MG et el. Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of 5 prospective cohorts. Arch Neurol. 2011 ; 68(2) : 207-13. https://doi.org/10.1001/archneurol.2010.367
  17. Chio A, Benzi G, Dossena M, Mutani R, Mora G. Severely in-creased risk of amyotrophic lateral sclerosis among Italian pro-fessional football players. Brain. 2005 ; 128(3) : 472-6. https://doi.org/10.1093/brain/awh373
  18. No Author. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study(ACTS) phase I-II Study Group. Arch Neurol. 1996 ; 53(2) : 141-7. https://doi.org/10.1001/archneur.1996.00550020045014
  19. Cedarbaum JM, Stambler N, Malta E et el. The ALSFRS-R: a revised ALS functional rating scale that incorporatesassessments of respiratory function. BNDF ALS study group.(Phase III). J Neurol Sci. 1999 ; 169(1-2) : 13-21. https://doi.org/10.1016/S0022-510X(99)00210-5
  20. Hillel AD, Miller RM, Yorkston K, Mcdonald E, Norris FH, Konikow N. Amyotrophic lateral sclerosis severity scale. Neuroepidemiology. 1989 ; 8(3) : 142-50. https://doi.org/10.1159/000110176
  21. Kim HY, Park KH, Ko SH et el. Korean version of Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised: A Pilot Study on the ReliabilityandValidity.J KoreanNeurolAssoc. 2007 ; 25(2) : 149-54.
  22. Bensimon G, Lacomblez L, Meninger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med. 1994 ; 330(9) : 585-91. https://doi.org/10.1056/NEJM199403033300901
  23. Pongrats D, Neyndorfer B, Fischer W. German open label trial of riluzole 50mg b.i.d in treatment of amyotrophic lateral sclerosis(ALS). J of Neurol Sci. 2000 ; 180(1-2) : 82-5. https://doi.org/10.1016/S0022-510X(00)00426-3
  24. Jun YW, Moon SK, Ko CN et el. Clinical study on the ALS(Amyotrophic Lateral Sclerosis) patients inthe Department of Cirulatory Internal Medicine of Kyung Hee Oriental Medical Hospital. Korean J. Orient .Int. Med. 1997 ; 18(2) : 236-45.
  25. Kwon KR. ClinicalStudies of Amyotrophic Lateral Sclerosis(ALS) through Korean Medicine. The Acupuncture. 2003 ; 20(3) : 209-16.
  26. Kim SC, Na WM, Lim NR, Lee DS, Jang EH, Song BK. A pilot study on the Traditional Korean treatment of Amyotrophic lateral sclerosis. Journal of Pharmacopuncture. 2009 ; 12(1) : 53-65. https://doi.org/10.3831/KPI.2009.12.1.053
  27. Park SJ, Jeong HH, Jang ES, Kim SH, Kim SC, Joo JC. Sasang Constituional Characteristic of Amyotrophic Lateral Sclerosis. J Sasang Constitut Med. 2014 ; 26(2) : 156-64. https://doi.org/10.7730/JSCM.2014.26.2.156
  28. Kim TY, Lee BJ, Jeon JH, Lew JH. A case of Amyotrophic Lateral Sclerosis. Korean J. Orient. Med. 2000 ; 21(4) : 661-5.
  29. Park BY, Lee EH, Ko H. A study on the Efficiency of Riluzole and Oriental Medical Treatment in Amyotrophic Lateral Sclerosis. Korean J. Orient. Med. 2001 ; 22(2) : 279-83.
  30. Kim KO, Jung SM, Jang JU, Shin YW. A case report on the patient with Amyotrophic Lateral Sclerosis(ALS). J Oriental Rehab Med. 2004 ; 14(2) : 129-36.
  31. Kim SH, Park JH, Park SJ, Byun SI, Kim JW, Hwang WW. One case report with a Amyotrophic Lateral Sclerosis(ALS) patient who has Hwabyung and Major Depressive Disorder. J Orient Neuropsychiatry. 2005 ; 16(2) : 159-69.
  32. Choi EH, Jeon JH, Kim YM et el. Clinical Observation on a Case of Patient with Amyotrophic Lateral Sclerosis. The Acupuncture. 2007 ; 24(4) : 225-35.
  33. Byun MK, Kim JY,Sim SH et el. Three cases of Amyotrophic Lateral Sclerosis Treated with Oriental Medical Therapy. Korean J. Orient. Int. Med. 2007 ; 28(4) : 937-47.
  34. Ryu MS, Wi J, Bang SP, Lee JE, Kim JH, Yun YC. 2 Cases of Amyotrophic Lateral Sclerosis (ALS) with Oriental Medical Treatment Evaluated by K-ALSFRS-R and ALSSS. The Acupuncture. 2009 ; 26(1) : 173-85.
  35. Im EY, Baek KM. The effect of Banhahooback-tang(Banxiaheobue-tang)inALS patient with progressive bulbar dysfunction. The Journal of East-West Medicine. 2009 ; 34(4) : 73-84.
  36. Kim HS, Song BG, Park MY, Lim NR, Kim SH, Kim SC. The follow-up study on patients of Amyotrophic Lateral Sclerosis after 1 year. Journal of Pharmacopuncture. 2010 ; 13(1) : 121-8. https://doi.org/10.3831/KPI.2010.13.1.121
  37. Ryu YJ, Lee KH, Kwon KR, Lee YH, Sun SH, Lee SJ. Mountain Ginseng Pharmacopuncture Treatment on Three Amyotrophic Lateral Sclerosis Patients. Journal of Pharmacopuncture. 2010 : 13(4) ; 119-28. https://doi.org/10.3831/KPI.2010.13.4.119
  38. Yeon CH, Pak HG, Jo YK, Jung JY, Lee SM, Kim SS. The Clilnical Case of Oriental Medical Treatment at Tender Point for Patient with Lower Back Pain Suggesting of Amyotrophic Lateral Sclerosis. J Korea CHUNA Med Spine& Nerves. 2010 ; 5(2) : 103-11.
  39. LeeSM, Kim SH, Jeong HH et el. Effects on Sa-am Acupuncture Treatment on a ALS(Amyotrophic Lateral Sclerosis) Patient. The Acupuncture. 2012 ; 29(5) : 187-95.
  40. Kim TJ, Moon AJ, Lee SG, Lee KS. A case of Amyotrophic Lateral Sclerosis. The Korean J Joongpoong. 2012 ; 13(1) : 77-85.
  41. Jeong HH, Kim SH, Lee SM et el. A Case Study on the use of Trihexyphenidyl, Korean Medical Treatment for the Control of Sialorrhea in Patients with Amyotrophic Lateral Sclerosis (ALS). The Acupuncture. 2013 ; 30(2) : 73-9. https://doi.org/10.13045/kamms.2013016
  42. Jeong HH, Lee SM, Lee JC et el. A Case Study on the Use of Megestrol Acetate and Korean Medical Treatment for the Loss of Appetiteand Weight Loss of Appetite and Weight Loss in Patients with Amyotrophic Lateral Sclerosis (ALS). The Acupuncture. 2013 ; 30(5) : 185-92. https://doi.org/10.13045/acupunct.2013057
  43. Lee SM, Jeong HH, Lee JC, Park MY, Kim SC. A Clinical Case Study on the Effects of Acupuncture Therapy and Ecklonia Cava Extract on Sleep Disturbances in ALS patients. The Acupuncture. 2013 ; 30(5) : 247-52. https://doi.org/10.13045/acupunct.2013064
  44. Lee JC, Jeong HH, Cha EH et el. A Clinical Case Study on the Long Term Respiration Management of Amyotrophic Lateral Sclerosis Patient whit Respiratory Failure. The Acupuncture. 2014 ; 31(3) : 67-73. https://doi.org/10.13045/acupunct.2014044
  45. Lou J, Reeves A, Benice T, Sexton G. Fatigue and depression are associated with poor quality of life in ALS. Neurology. 2003 ; 60(1) : 122-3. https://doi.org/10.1212/01.WNL.0000042781.22278.0A
  46. Lo Coco D, Mattalino P, Sparatol R, Mattaliano A, La Bella, V. Sleep-wake Disturbances in Patients with Amyotrophic Lateral Sclerosis. Journal of Neurol Neurosurg Psychiatry. 2011 ; 82(8) : 839-42. https://doi.org/10.1136/jnnp.2010.228007

피인용 문헌

  1. Traditional East Asian Herbal Medicine for Amyotrophic Lateral Sclerosis: A Scoping Review vol.2021, pp.None, 2015, https://doi.org/10.1155/2021/5674142